Can CSF spectrophotometry for “Xanthochromia” be used to detect leaking subarachnoid aneurysms in patients with sickle cell anemia with negative MRI or CT angiogram despite hyperbilirubinemia?

Can CSF spectrophotometry for “Xanthochromia” be used to detect leaking subarachnoid aneurysms in patients with sickle cell anemia with negative MRI or CT angiogram despite hyperbilirubinemia?

Abstract CSF (Cerebrospinal Fluid) xanthochromia by spectroscopy should not be dismissed in the context of hyperbilirubinemia in a patient with sickle cell anemia. Xanthochromia detected by spectrophotometry offers a vital clue that further invasive diagnosis is required.

Bibliographic Details
Main Authors: Wan Yung Siu, William Thomas, Rikin Trivedi, Alexandra Hogan, Umbareen Siddiqi, Anita Sarker, Martin Wolfgang Besser
Format: Article
Language:English
Published: Wiley 2020-05-01
Series:Clinical Case Reports
Subjects:
CSF xanthochromia
polycystic kidney disease
Sickle cell anemia
spectroscopy
subarachnoid hemorrhage
Online Access:https://doi.org/10.1002/ccr3.2775

Internet

https://doi.org/10.1002/ccr3.2775

Similar Items